Board Wants More Testimony Before Vote on Allowing Medical Marijuana for Opiate Withdrawal

The board recommended adding brittle bone disease to the program.

The board that votes on which medical conditions medical marijuana can be used to treat in Connecticut is asking for more testimony on opioid use disorder before voting on whether to allow those who have it to use medical marijuana.

“The opioid crisis is a serious matter that has affected far too many families in our state, and throughout the country,” Consumer Protection Commissioner Michelle H. Seagull said in a statement. “We know that there is no one solution to this challenge, but that thoughtful consideration of many options can help us combat this crisis. I want to thank the brave survivors of addiction who testified at the Board’s public hearing on this issue, and welcome the written testimony of more members of the public, and the medical community.” 

The Board of Physicians will accept additional written testimony until Friday, March 30 at 5 p.m. 

Members are particularly interested in testimony from mental health and addiction specialists, but testimony from all members of the public will be accepted. Email testimony to using the subject line “Board of Physicians Testimony.” 

Testimony will be sent in a package to the Board of Physicians before the next public meeting so members can review it. 

While the Board will only be accepting written testimony and asking follow-up questions to specific people who submit testimony ahead of the meeting, members of the public can attend the meeting and the board will deliberate publicly.

The Office of the Attorney General must review the board’s recommendations and the regulations review committee of the General Assembly must approve them. 

Contact Us